bromocriptine has been researched along with ergonovine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
Anlezark, G; Meldrum, B | 1 |
Anlezark, GM; Horton, RW; Meldrum, BS | 1 |
Dreyer, NA; Funch, DP; Rothman, KJ | 1 |
Gorelli, B; Mantovani, P; Santicioli, P; Taddei, E | 1 |
Larson, BT; Rowell, PP | 1 |
Akaike, A; Izumi, Y; Kume, T; Niidome, T; Oda, T; Takada-Takatori, Y | 1 |
8 other study(ies) available for bromocriptine and ergonovine
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.
Topics: Allyl Compounds; Animals; Bromocriptine; Dopamine; Electroencephalography; Epilepsy; Ergolines; Ergonovine; Ergot Alkaloids; Haplorhini; Lysergic Acid Diethylamide; Papio; Photic Stimulation | 1978 |
Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
Topics: Acoustic Stimulation; Animals; Apomorphine; Biogenic Amines; Brain; Bromocriptine; Dopamine; Ergolines; Ergonovine; Female; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred DBA; Quipazine; Seizures | 1978 |
Bromocriptine and puerperal seizures.
Topics: Adolescent; Adult; Bromocriptine; Case-Control Studies; Confidence Intervals; Drug Interactions; Ergonovine; Female; Humans; Lactation; Puerperal Disorders; Risk; Seizures; Time Factors | 1990 |
Effect of bromocriptine and ergometrine on striatal acetylcholine content in the rat.
Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Ergonovine; Rats; Receptors, Dopamine | 1988 |
Ergocryptine and other ergot alkaloids stimulate the release of [3H]dopamine from rat striatal synaptosomes.
Topics: Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Ergonovine; Ergotamine; Male; Rats; Rats, Sprague-Dawley; Synaptosomes | 1999 |
Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
Topics: Animals; Azepines; Benzothiazoles; Blotting, Western; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergonovine; Ergot Alkaloids; Methylergonovine; Mitogen-Activated Protein Kinases; Neurites; PC12 Cells; Pramipexole; Rats; Receptors, Dopamine D2 | 2008 |